Topic Development Process

1. Topic Suggestions Suggestions for PAD topics are accepted from physicians, pharmacists, nurses, other health care professionals, advisory committees, Pharmaceutical Services Division staff and others.
2. Topic Selection The following factors are considered in selecting a topic:
  • Disease impact
  • Known therapeutic dilemma or controversy
  • New evidence on efficacy and/or safety
  • Urgency of educational needs
  • Interest to family physicians
  • Expected magnitude of health outcomes as a result of education
  • Ability to discuss the evidence in 15 to 60 minutes
  • Potential impact on drug programs
  • Potential synergy and impact on other areas of the healthcare system
3. Topic Scoping Topic scoping includes PICO-style research questions for areas of interest. Clinical experts in the area are consulted as needed.
4. Topic Research Detailed literature searches and critical appraisals of relevant evidence are completed for each research question and the results compiled in summary documents. Additional searches and critical appraisals are completed for important issues identified during initial searches. Clinical experts in the topic area are consulted as needed.
5. Key Messages Three to five key messages are developed based on the research findings. Clinical experts in the topic areas are consulted as needed.
6.Detailing Materials Detailing materials, such as information sheets, newsletters, and/or drug tables are created to support the detailing pharmacists in discussing the key messages.
7. Upskilling Information relevant to the topic is provided to detailing pharmacists through a combination of self-directed learning, assigned readings, telephone/video conferencing, in-person sessions, and attendance at relevant conferences.
8. External Review Draft versions of the key messages, summary documents and detailing materials are reviewed externally by family physicians, clinical experts, professional organizations and patient advocacy groups and academic detailing programs in other provinces.
9. Final Materials Key messages, summary documents and detailing materials are revised as needed based on feedback received from external reviewers. Reviewers may be contacted to clarify comments and/or to provide additional input.A complete list of references is available from the academic detailing pharmacists
10. CME Accreditation MainPro M1 accreditation is obtained through UBC’s Faculty of Medicine’s Division of Continuing Professional Development.
11. Approval Final approval of all detailing materials is obtained from the Executive Director of Drug Intelligence and Optimization.
12. Topic Launch Detailing pharmacists begin academic detailing sessions with family physicians, nurse practitioners and pharmacists. Other health professionals may be included depending on the topic.